1. Submission Criteria



 
 


 CRPA


CRE


Recommended isolate


P. aeruginosa that are resistant to at least one imipenem, meropenem, or doripenem AND Nonsusceptible (intermediate or resistant) to cefepime or ceftazidime


Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Enterobacter spp. that are resistant to any imipenem, meropenem, doripenem, or ertapenem.


Providenicia, Proteus, Morganella, Citrobacter and Serratia that are resistant to any meropenem, doripenem, or ertapenem. 


CLSI breakpoints

 New left Antibiotic chart green

NewAntibiotic chart middle 


Specimen type


Any: non-inhibitory, non-selective agar plate or slant (e.g. Sheep blood agar, Tryptic soy agar, etc.), broth    

Lab testing offered


MALDI-TOF mass spectrometry

Antimicrobial susceptibility testing (AST)

Modified Carbapenem Inactivation Method (mCIM)

Real-time polymerase chain reaction (PCR) 


 Back to main page image


Last updated October 6, 2020